![French rap singer K-Maro performs live in Thonex, Switzerland on March 31, 2006. Photo by Max/ABACAPRESS.COM Stock Photo - Alamy French rap singer K-Maro performs live in Thonex, Switzerland on March 31, 2006. Photo by Max/ABACAPRESS.COM Stock Photo - Alamy](https://l450v.alamy.com/450v/2e99nrw/french-rap-singer-k-maro-performs-live-in-thonex-switzerland-on-march-31-2006-photo-by-maxabacapresscom-2e99nrw.jpg)
French rap singer K-Maro performs live in Thonex, Switzerland on March 31, 2006. Photo by Max/ABACAPRESS.COM Stock Photo - Alamy
![Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics and treatment regimens | bioRxiv Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics and treatment regimens | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/10/19/2020.10.19.344960/F7.large.jpg)
Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics and treatment regimens | bioRxiv
![Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife](https://iiif.elifesciences.org/lax/64116%2Felife-64116-fig3-figsupp2-v2.tif/full/1500,/0/default.jpg)
Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife
![Microorganisms | Free Full-Text | Innovative Strategies to Overcome Antimicrobial Resistance and Tolerance Microorganisms | Free Full-Text | Innovative Strategies to Overcome Antimicrobial Resistance and Tolerance](https://pub.mdpi-res.com/microorganisms/microorganisms-11-00016/article_deploy/html/images/microorganisms-11-00016-g001.png?1671713022)
Microorganisms | Free Full-Text | Innovative Strategies to Overcome Antimicrobial Resistance and Tolerance
![Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife](https://iiif.elifesciences.org/lax/64116%2Felife-64116-fig1-figsupp1-v2.tif/full/full/0/default.jpg)
Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife
![Pharmaceutics | Free Full-Text | Innovative Insights into In Vitro Activity of Colloidal Platinum Nanoparticles against ESBL-Producing Strains of Escherichia coli and Klebsiella pneumoniae Pharmaceutics | Free Full-Text | Innovative Insights into In Vitro Activity of Colloidal Platinum Nanoparticles against ESBL-Producing Strains of Escherichia coli and Klebsiella pneumoniae](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-14-01714/article_deploy/html/images/pharmaceutics-14-01714-g003.png?1660728756)
Pharmaceutics | Free Full-Text | Innovative Insights into In Vitro Activity of Colloidal Platinum Nanoparticles against ESBL-Producing Strains of Escherichia coli and Klebsiella pneumoniae
![Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife](https://iiif.elifesciences.org/lax/64116%2Felife-64116-fig2-v2.tif/full/1500,/0/default.jpg)
Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife
![Activities of Fosfomycin, Tigecycline, Colistin, and Gentamicin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Foreign-Body Infection Model | Antimicrobial Agents and Chemotherapy Activities of Fosfomycin, Tigecycline, Colistin, and Gentamicin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Foreign-Body Infection Model | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.01718-12/asset/b937e833-ddc4-40d3-8518-34840622fb08/assets/graphic/zac9991016560002.jpeg)
Activities of Fosfomycin, Tigecycline, Colistin, and Gentamicin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Foreign-Body Infection Model | Antimicrobial Agents and Chemotherapy
![Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife Figures and data in Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics, and treatment regimens | eLife](https://iiif.elifesciences.org/lax/64116%2Felife-64116-fig2-figsupp2-v2.tif/full/,1500/0/default.jpg)